Have We Entered A Stealth Bear Market?
ADMA Biologics Inc ADMA
$8.46
▼ -2.42%
($-0.21)
⬇️ Below Yest. Low
📅 Earnings This Week
Open
$8.58
Prev Close
$8.67
Day Range
$8.35 – $8.66
52W Range
$7.21 – $20.46
Market Cap
$1.96B
P/E (TTM)
12.03
Beta
0.79
EPS (TTM)
$0.68
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2013-10-17 |
| Shares Out. | 231,770,000 |
| Website | admabiologics.com/ ↗ |
| Phone | 12014785552 |
| Employees | 647 |
| Revenue | $114.5M |
| Gross Profit | $80.8M |
| Net Income | $45.3M |
| Free Cash Flow | $107.9M |
| Total Assets | $665.2M |
| Total Liabilities | $274.9M |
| Equity | $390.3M |
About ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
ADMA Biologics Inc is a publicly traded company under the ticker symbol ADMA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-07-01)